How safe are new disease modifying drugs in the treatment of multiple sclerosis?


Brain scans

Multiple Sclerosis (MS) is a chronic disease of the brain and spinal cord often affecting young adults. Injectable disease modifying drugs (DMDs) to treat MS were introduced in Canada in 1995. In recent years, three new oral DMDs have been approved by Health Canada to treat MS, with two of them approved as first-line therapies.

Subscribe to